ArticlePloS one2025
Prevalence and associated factors of chronic kidney disease among adults receiving antiretroviral therapy at Hawassa University Comprehensive Specialized Hospital.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntiretroviral therapy (ART) improves life expectancy in people living with human immunodeficiency virus (HIV). The risk of chronic kidney disease (CKD) is greater in people living with HIV (PLWH) than in the general population, and it is becoming a significant public health issue, increasing disease progression and complicating treatment. However, patients in Africa are not routinely screened due to resource constraints, which leads to a high CKD burden. Identifying the predisposing factors is the crux of mitigating the burden of CKD. We investigate the prevalence of chronic kidney disease and associated factors among PLWH at the Hawassa University Comprehensive Specialized Hospital (HUCSH).
methodsA cross-sectional study was conducted from August 2 to September 3, 2022, at the HUCSH ART clinic, in Hawassa, Ethiopia. Data were collected from 338 PLWH through interview and medical record review. Renal function was assessed using the estimated glomerular filtration rate (eGFR) calculated using the "Chronic Kidney Disease Epidemiology Collaboration" (CKD-EPI) formula. Data were entered in Epidata version 3.01 and analyzed using Statistical Package for the Social Sciences (SPSS) version 26.0. Both bivariable and multivariable logistic regression analyses were used to identify factors associated with CKD among PLWH. An adjusted odds ratio (AOR) with a 95% Confidence Interval (CI) was reported to show the strength of the association. The goodness of fit of the model was checked by the Hosmer and Lemeshow test. The statistical significance of associations was declared at a p-value < 0.05.
resultsThe study included 338 PLWH with a response rate of 96%. The mean (standard deviation (SD) age of the participants was 44.4 ( ± 10.9) years. The female-to-male ratio was 1:1.8. The prevalence of CKD was 7.7% [95% CI: 5-10.7%]. History of alcohol use [AOR: 5.4; 95%CI: 1.32, 21.7], having chronic medical illness [AOR: 5.3; 95%CI: 1.45, 19.1], late stage of HIV [AOR: 5.2; 95%CI: 1.1, 25.3], opportunistic infections [AOR: 5.4; 95%CI: 1.25, 23.4], and low baseline hemoglobin level [AOR: 7.9; 95%CI: 2.58, 24.4] were significantly associated with CKD.
conclusionThe study found that CKD prevalence in PLWH was high. Factors associated with CKD include alcohol use, chronic medical illness, advanced WHO HIV stage, opportunistic infections, and low hemoglobin. Therefore, PLWH should be regularly screened for early diagnosis and management of CKD, and those with associated factors should be closely monitored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.